110 related articles for article (PubMed ID: 9215822)
1. Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE.
Rijks LJ; Bakker PJ; van Tienhoven G; Noorduyn LA; Boer GJ; Rietbroek RC; Taat CW; Janssen AG; Veenhof CH; van Royen EA
J Clin Oncol; 1997 Jul; 15(7):2536-45. PubMed ID: 9215822
[TBL] [Abstract][Full Text] [Related]
2. In vivo prediction of response to antiestrogen treatment in estrogen receptor-positive breast cancer.
Bennink RJ; van Tienhoven G; Rijks LJ; Noorduyn AL; Janssen AG; Sloof GW
J Nucl Med; 2004 Jan; 45(1):1-7. PubMed ID: 14734659
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor status in primary breast cancer: iodine 123-labeled cis-11beta-methoxy-17alpha-iodovinyl estradiol scintigraphy.
Bennink RJ; Rijks LJ; van Tienhoven G; Noorduyn LA; Janssen AG; Sloof GW
Radiology; 2001 Sep; 220(3):774-9. PubMed ID: 11526281
[TBL] [Abstract][Full Text] [Related]
4. The Z-isomer of 11 beta-methoxy-17 alpha-[123I]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancer.
Rijks LJ; Boer GJ; Endert E; de Bruin K; Janssen AG; van Royen EA
Nucl Med Biol; 1997 Jan; 24(1):65-75. PubMed ID: 9080477
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging.
Rijks LJ; Busemann Sokole E; Stabin MG; de Bruin K; Janssen AG; van Royen EA
Eur J Nucl Med; 1998 Jan; 25(1):40-7. PubMed ID: 9396873
[TBL] [Abstract][Full Text] [Related]
6. The stereoisomers of 17alpha-[123I]iodovinyloestradiol and its 11beta-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats.
Rijks LJ; Boer GJ; Endert E; de Bruin K; van den Bos JC; van Doremalen PA; Schoonen WG; Janssen AG; van Royen EA
Eur J Nucl Med; 1996 Mar; 23(3):295-307. PubMed ID: 8599961
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Doornbos T; Vekemans JA; Posthumus MA; Janssen AG; van Royen EA
Nucl Med Biol; 1998 May; 25(4):411-21. PubMed ID: 9639304
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution, dosimetry and metabolism of 11beta-methoxy-(17alpha,20E/Z)-[123I]iodovinylestradiol in healthy women and breast cancer patients.
Nachar O; Rousseau JA; Lefebvre B; Ouellet R; Ali H; van Lier JE
J Nucl Med; 1999 Oct; 40(10):1728-36. PubMed ID: 10520716
[TBL] [Abstract][Full Text] [Related]
9. Scintimammography with 11beta-methoxy-(17alpha,20Z)-[123I]iodovinylestrad iol: a complementary role to 99mTc-methoxyisobutyl isonitrile in the characterization of breast tumors.
Nachar O; Rousseau JA; Ouellet R; Rioux A; Lefebvre B; Ali H; van Lier JE
J Nucl Med; 2000 Aug; 41(8):1324-31. PubMed ID: 10945522
[TBL] [Abstract][Full Text] [Related]
10. [Tumor scintigraphy using 123I-labeled estradiol in breast cancer--receptor scintigraphy].
Scheidhauer K; Müller S; Smolarz K; Bräutigam P; Briele B
Nuklearmedizin; 1991 Jun; 30(3):84-99. PubMed ID: 1871007
[TBL] [Abstract][Full Text] [Related]
11. Iodine-labeled tamoxifen uptake in primary human breast carcinoma.
Van de Wiele C; Cocquyt V; VandenBroecke R; De Vos F; Van Belle S; Dhaene K; Slegers G; Dierckx RA
J Nucl Med; 2001 Dec; 42(12):1818-20. PubMed ID: 11752079
[TBL] [Abstract][Full Text] [Related]
12. Images of estrogen-receptor-positive breast tumors produced by estradiol labeled with iodine I 123 at 16 alpha.
Kenady DE; Pavlik EJ; Nelson K; van Nagell JR; Gallion H; DePriest PD; Ryo UY; Baranczuk RJ
Arch Surg; 1993 Dec; 128(12):1373-81. PubMed ID: 8250712
[TBL] [Abstract][Full Text] [Related]
13. PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma.
van Kruchten M; Glaudemans AW; de Vries EF; Beets-Tan RG; Schröder CP; Dierckx RA; de Vries EG; Hospers GA
J Nucl Med; 2012 Feb; 53(2):182-90. PubMed ID: 22241912
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
[TBL] [Abstract][Full Text] [Related]
15. Can fluorine-18 fluoroestradiol positron emission tomography-computed tomography demonstrate the heterogeneity of breast cancer in vivo?
Yang Z; Sun Y; Zhang Y; Xue J; Wang M; Shi W; Zhu B; Hu S; Yao Z; Pan H; Zhang Y
Clin Breast Cancer; 2013 Oct; 13(5):359-63. PubMed ID: 23787040
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
17. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
[TBL] [Abstract][Full Text] [Related]
18.
Nienhuis HH; van Kruchten M; Elias SG; Glaudemans AWJM; de Vries EFJ; Bongaerts AHH; Schröder CP; de Vries EGE; Hospers GAP
J Nucl Med; 2018 Aug; 59(8):1212-1218. PubMed ID: 29602822
[TBL] [Abstract][Full Text] [Related]
19. Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol.
Peterson LM; Mankoff DA; Lawton T; Yagle K; Schubert EK; Stekhova S; Gown A; Link JM; Tewson T; Krohn KA
J Nucl Med; 2008 Mar; 49(3):367-74. PubMed ID: 18287268
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen.
Khoshnoud MR; Löfdahl B; Fohlin H; Fornander T; Stål O; Skoog L; Bergh J; Nordenskjöld B
Breast Cancer Res Treat; 2011 Apr; 126(2):421-30. PubMed ID: 20957430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
